270.79MMarket Cap
14.56P/E TTM
Niagen Bioscience Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Niagen Bioscience Inc is 5.53, ranking 362 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 14.56, which is 330.78% below the recent high of 62.72 and 64.43% above the recent low of 5.18.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.